# FDA Inspection 1220213 - Patricia Seabra MD - September 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/patricia-seabra-md/aac0e486-6662-4a43-a9a9-4c26d6f65563
Source feed: FDA_Inspections

> FDA Inspection 1220213 for Patricia Seabra MD on September 22, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220213
- Company Name: Patricia Seabra MD
- Inspection Date: 2023-09-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/patricia-seabra-md/08be985c-312b-490d-bc92-d402ddb2402e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c